Home›People›Caroline Popper
Caroline Popper

Caroline Popper

Strategic Advisor, Commercialization & Market Access at Pangia Biotech.

Executive
Updated Nov 10, 2026·Latest SEC filing May 11, 2026·Suggest an edit

About Caroline Popper

Caroline Popper is a strategic advisor, commercialization & market access at Pangia Biotech.

Experience

This experience comes from SEC filings. The years are when the filings name Caroline Popper in the role, so the role may have started earlier or lasted longer.

Pangia Biotech, Inc.
Strategic Advisor, Commercialization & Market Access
2026 · Delray Beach, FL
Develops urine-based cancer tests for clinicians and patients.

Key Colleagues at Startups

The people Caroline Popper works with at each company, as listed on that company's latest Form D.

Pangia Biotech, Inc. · Form D, May 11, 2026
OP
Obdulio Piloto
Chief Scientific Officer and Co-Founder
GR
Garth Lees-Rolfe
Audit Committee Chair
HM
Holly Magliochetti
CEO and Co-Founder, director

Sources

  1. SECPangia Biotech, Inc. Form D, filed May 11, 2026